PPA
PRAX icon

Parametric Portfolio Associates’s Praxis Precision Medicines PRAX Stock Holding History

Parametric Portfolio Associates’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,332
Closed -$394K – 3747
2021
Q4 		$394K Buy
1,332
+278
+26% +$81.5K ﹤0.01% 3162
2021
Q3 		$292K Buy
+1,054
New +$286K ﹤0.01% 3312

Other funds holding PRAX

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Parametric Portfolio Associates's PRAX Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Praxis Precision Medicines (PRAX) in Q1 2022, closing a stake of 1,332 shares — an estimated $394K sold.

Parametric Portfolio Associates first reported a position in PRAX in Q3 2021 and held it in 2 quarters. The position peaked at $394K in Q4 2021. 104 funds tracked by Wall St. Rank hold PRAX as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Praxis Precision Medicines position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,332 Praxis Precision Medicines shares in Q1 2022, an estimated $394K.
  • Parametric Portfolio Associates first reported a position in Praxis Precision Medicines in Q3 2021 and held it in 2 quarters.
  • Parametric Portfolio Associates's Praxis Precision Medicines position peaked at $394K in Q4 2021.
  • 104 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.